glp 1 receptor agonists Potential Use of GLP-1 and GIP/GLP-1 for Respiratory Disorders: Where Are We at? GLP-1 Receptor Agonists Explained for
Description
doi: 10.1038/s41467-020-18751-8 59 KillionEAWangJYieJShiSDBatesDMinXet al

GLP1-RA and Weight Loss Boom in India

Physiol Rev 87: 1409-1439, 2007

[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Bretn-Romero R., Weisbrod R.M., Feng B., Holbrook M., Ko D., Stathos M.M., Zhang J., Fetterman J.L., Hamburg N.M

Forward-looking statements in this news release include, but are not limited to, statements regarding the development, advancement, regulatory pathway, and potential commercialization of BNT23001, the Company's patented sublingual Cladribine orally dissolvable film ("ODF") program for multiple sclerosis

10.1016/j.mvr.2018.07.005 30
